Appropriate prescribing and deprescribing in robust and frail older patients

Australian Family Physician

Volumn 41, Issue 12, 2012, Pages 924-928

  Hilmer, Sarah N ^a   Gnjidic, Danijela ^b   Le Couteur, David G ^c  

^a UNIVERSITY OF SYDNEY   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

^c Department of Microbiology and Infectious Diseases   (Australia)

Author keywords

Deprescribing; Drug prescriptions; Elderly; Polypharmacy

Indexed keywords

ANTIHYPERTENSIVE AGENT; ANTIINFECTIVE AGENT; ANTITHROMBOCYTIC AGENT; FIBRINOLYTIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; SULFONYLUREA DERIVATIVE;

AGED; ARTICLE; BENEFICENCE; CLINICAL PRACTICE; COMORBIDITY; ETHICS; FRAIL ELDERLY; HEALTH STATUS; HUMAN; METHODOLOGY; PATIENT CARE PLANNING; POLYPHARMACY; PRIMARY HEALTH CARE; RISK ASSESSMENT;

AGED; ANTI-BACTERIAL AGENTS; ANTIHYPERTENSIVE AGENTS; BENEFICENCE; COMORBIDITY; FIBRINOLYTIC AGENTS; FRAIL ELDERLY; HEALTH STATUS; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; PATIENT CARE PLANNING; PHYSICIAN'S PRACTICE PATTERNS; PLATELET AGGREGATION INHIBITORS; POLYPHARMACY; PRIMARY HEALTH CARE; RISK ASSESSMENT; SULFONYLUREA COMPOUNDS;

EID: 84871144239     PISSN: 03008495     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Le Couteur DG, Hilmer SN, Glasgow N, Naganathan V, Cumming RG. Prescribing in older people. Aust Fam Physician 2004, 33, 777-81.
2. Fried LP, Tangen CM, Walston J, et al. Frailty in older adults, evidence for a phenotype. J Gerontol A Biol Sci Med Sci 2001, 56, M146-56.
3. Rockwood K, Mitnitski A. Frailty in relation to the accumulation of deficits. J Gerontol A Biol Sci Med Sci 2007, 62, 722-7.
4. Hilmer SN, Perera V, Mitchell S, et al. The assessment of frailty in older people in acute care. Australas J Ageing 2009, 28, 182-8.
5. Hubbard RE, O'Mahony MS, Woodhouse KW. Medication prescribing in frail older people. Eur J Clin Pharmacol 2012 Sep 11 [Epub ahead of print].
6. Hilmer SN, Gnjidic D. The effects of polypharmacy in older adults. Clin Pharmacol Ther 2009, 85, 86-8.
7. Gnjidic D, Hilmer SN, Blyth FM, et al. High-risk prescribing and incidence of frailty among older community-dwelling men. Clin Pharmacol Ther 2012, 91, 521-8.
8. Hilmer SN, Mager DE, Simonsick EM, et al. A drug burden index to define the functional burden of medications in older people. Arch Intern Med 2007, 167, 781-7.
9. Budnitz DS, Lovegrove MC, Shehab N, Richards CL. Emergency hospitalizations for adverse drug events in older Americans. N Engl J Med 2011, 365, 2002-12.
10. Boyd CM, Darer J, Boult C, Fried LP, Boult L, Wu AW. Clinical practice guidelines and quality of care for older patients with multiple comorbid diseases, implications for pay for performance. JAMA 2005, 294, 716-24.
11. Hilmer SN, McLachlan AJ, Le Couteur DG. Clinical pharmacology in the geriatric patient. Fundam Clin Pharmacol 2007, 21, 217-30.
12. Berry SD, Ngo L, Samelson EJ, Kiel DP. Competing risk of death, an important consideration in studies of older adults. J Am Geriatr Soc 2010, 58, 783-7.
13. Beer C, Hyde Z, Almeida OP, et al. Quality use of medicines and health outcomes among a cohort of community dwelling older men, an observational study. Br J Clin Pharmacol 2011, 71, 592-9.
14. Iyer S, Naganathan V, McLachlan AJ, Le Couteur DG. Medication withdrawal trials in people aged 65 years and older, a systematic review. Drugs Aging 2008, 25, 1021-31.
15. Garfinkel D, Mangin D. Feasibility study of a systematic approach for discontinuation of multiple medications in older adults, addressing polypharmacy. Arch Intern Med 2010, 170, 1648-54.
16. Hardy JE, Hilmer SN. Deprescribing in the final year of life. Journal of Pharmacy Practice and Research 2011, 411, 148-51.
17. Beer C, Loh P, Peng YG, Potter K, Millar A. A pilot randomised controlledtrial of deprescribing. Ther Adv Drug Saf 2011, 2, 37-43.
18. Le Couteur DG, Banks E, Gnjidic D, McLachlan AJ. Deprescribing. Aust Prescr 2011, 34, 182-5.
19. Hilmer SN, Gnjidic D, Abernethy DR. Pharmacoepidemiology in the postmarketing assessment of the safety and efficacy of drugs in older adults. J Gerontol A Biol Sci Med Sci 2012, 67, 181-8.
20. Seshasai SR, Wijesuriya S, Sivakumaran R, et al. Effect of aspirin on vascular and nonvascular outcomes, meta-analysis of randomized controlled trials. Arch Intern Med 2012, 172, 209-16.
21. Stroke Prevention in Atrial Fibrillation Study. Final results. Circulation 1991, 84, 527-39.
22. Perera V, Bajorek BV, Matthews S, Hilmer SN. The impact of frailty on the utilisation of antithrombotic therapy in older patients with atrial fibrillation. Age Ageing 2009, 38, 156-62.
23. Morgan TK, Williamson M, Pirotta M, Stewart K, Myers SP, Barnes J. A national census of medicines use, a 24-hour snapshot of Australians aged 50 years and older. Med J Aust 2012, 196, 50-3.
24. Roberts CG, Guallar E, Rodriguez A. Efficacy and safety of statin monotherapy in older adults, a meta-analysis. J Gerontol A Biol Sci Med Sci 2007, 62, 879-87.
25. Sontheimer D. Review, statins reduce all-cause mortality in elderly patients with coronary heart disease. ACP J Club 2008, 148, 3.
26. National Institute for Health and Clinical Excellence. Statins for the prevention of cardiovascular events. 2006.
27. Hilmer SN, Gnjidic D. Statins in older adults. Aust Prescr 2012, in press.
28. Musini VM, Tejani AM, Bassett K, Wright JM. Pharmacotherapy for hypertension in the elderly. Cochrane Database Syst Rev 2009(4), CD000028.
29. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet 1998, 352, 837-53.
30. eTG complete [Internet]. Melbourne, Therapeutic Guidelines Limited, 2012. Available at www.tg.org.au/etg_demo/tgc/about/5a57c76.htm.
31. Hilmer SN, Tran K, Rubie P, et al. Gentamicin pharmacokinetics in old age and frailty. Br J Clin Pharmacol 2011, 71, 224-31.
32. Le Couteur DG, Kendig H, Naganathan V, McLachlan AJ. The ethics of prescribing medications to older people. In, Koch S, editor. Medication management in older adults, a concise guide for clinicians. Springer Science + Business Media 2010, 29-42.
33. Rochon PA, Gurwitz JH. Optimising drug treatment for elderly people, the prescribing cascade. BMJ 1997, 315, 1096-9.
34. Tinetti ME, McAvay GJ, Fried TR, et al. Health outcome priorities among competing cardiovascular, fall injury, and medication-related symptom outcomes. J Am Geriatr Soc 2008, 56, 1409-16.
35. Kemp A, Roughead E, Preen D, Glover J, Semmens J. Determinants of selfreported medicine underuse due to cost, a comparison of seven countries. J Health Serv Res Policy 2010, 15, 106-14.
36. Gnjidic D, Le Couteur DG, Kouladjian L, Hilmer SN. Deprescribing trials, methods to reduce polypharmacy and the impact on prescribing and clinical outcomes. Clin Geriatr Med 2012, 28, 237-53.
37. Patterson SM, Hughes C, Kerse N, Cardwell CR, Bradley MC. Interventions to improve the appropriate use of polypharmacy for older people. Cochrane Database Syst Rev 2012, 5, CD008165.
38. Colon-Emeric CS, Mesenbrink P, Lyles KW, et al. Potential mediators of the mortality reduction with zoledronic acid after hip fracture. J Bone Miner Res 2009, 25, 91-7.